-
1Academic Journal
Authors: D. V. Abbasova, S. B. Polikarpova, N. A. Kozlov, A. S. Markova, E. A. Bogush, V. Yu. Kirsanov, Д. В. Аббасова, С. Б. Поликарпова, Н. А. Козлов, А. С. Маркова, Е. А. Богуш, В. Ю. Кирсанов
Source: Cancer Urology; Том 15, № 2 (2019); 126-133 ; Онкоурология; Том 15, № 2 (2019); 126-133 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2019-15-2
Subject Terms: нейроэндокринные неоплазии редких локализаций, neuroendocrine tumors of the kidney, neuroendocrine carcinoma, neuroendocrine carcinoma of rare localizations, нейроэндокринный рак почки, нейроэндокринные неоплазии
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/892/848; Lane B.R., Chery F., Jour G. et al. Renal neuroendocrine tumours. Indian J Urol 2009;25(2):155–60. DOI:10.4103/09701591.52905.; El-Naggar A.K., Troncoso P., Ordonez N.G. Primary renal carcinoid tumor with molecular abnormality characteristic of conventional renal neoрlasm. Diagn Mol Pathol 1995;4(1):48–53. PMID: 7735556.; Cao D., Selli B.W., Clapp W.L. et al. Primary renal carcinoid tumors: clinicopathologic features of 9 cases with emphasis on novel immunohistochemical findings. Hum Patol 2011;42(10):1554–61. DOI:10.1016/j.humpath.2010.12.019. PMID: 21496872.; Romero F.R., Rais-Bahrami S., Permpongkosol S. et al. Primary carcinoid tumors of the kidney. J Urol 2006; 176(6 Pt 1):2359–66. PMID: 17085102.; The WHO Classification of Tumours of the Urinary System and Male Genital Organs presented in this book reflects the views of a Working Group that convened for an Editorial and Consensus and Editorial Meeting at the University Hospital Zürich. Zürich, 11–13 March 2015.; Omiyale A.O., Venyo A.K. Primary carcinoid tumour of the kidney: a review of the literature. Adv Urol 2013;2013:579396. DOI:10.1155/2013/579396. PMID: 23997766.; Teegavarapu P.S., Rao P., Matrana M., Cauley D.H. et al. Neuroendocrine tumors of the kidney: a single institution experience. Clin Genitourin Cancer 2014;12(6):422–7. DOI:10.1016/j.clgc.2014.06.008. PMID: 25088468.; Moukassa D., Leroy X., Bouchind’homme B. et al. Primary large cell neuroendocrine carcinoma of the kidney: morphologic and immunohistochemical features of two cases. Ann Pathol 2000;20(4):357–60. PMID: 11015655.; Lane B.R., Chery F., Jour G. et al. Renal neuroendocrine tumours: a clinicopathological study. BJU Int 2007;100(5):1030–5. DOI:10.1111/j.1464-410X.2007.07116.x. PMID: 17784891.; Ratnagiri R., Singh S.S., Majhi U. et al. Large-cell neuroendocrine carcinoma of the kidney: clinicopathologic features. Indian J Urol 2009;25(2):274–5. DOI:10.4103/0970-1591.52928. PMID: 19672368.; Palumbo C., Talso M., Dell’Orto P.G. et al. Primary large cell neuroendocrine carcinoma of the renal pelvis: a case report. Urologia 2014;81(1):57–9. DOI:10.5301/urologia.5000033. PMID: 24474544.; Wann C., John N.T., Kumar R.M. Primary renal large cell neuroendocrine carcinoma in a young man. J Clin Diagn Res 2014;8(11):ND08–9. DOI:10.7860/JCDR/2014/9443.5179. PMID: 25584263.; Shimbori M., Osaka K., Kawahara T. et al. Large cell neuroendocrine carcinoma of the kidney with cardiac metastasis: a case report. J Med Case Rep 2017;11(1):297. DOI:10.1186/s13256-017-1460-7. PMID: 29052535.; Majhail N.S., Elson P., Bukowski R.M. Therapy and outcome of small cell carcinoma of the kidney: report of two cases and a systematic review of the literature. Cancer 2003;97(6):1436–41. DOI:10.1002/cncr.11199. PMID: 12627507.; La Rosa S., Bernasconi B., Micello D. et al. Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural and cytogenetic study of a case and review of the literature. Endocr Pathol 2009;20(1):24–34. DOI:10.1007/s12022008-9054-y. PMID: 19096940.; Dundr P., Pesl M., Povýsil C. et al. Primary large cell neuroendocrine carcinoma of the kidney. Pathol Oncol Res 2010;16(1):139–42. DOI:10.1007/s12253009-9180-y. PMID: 19579058.; Kaufmann O., Georgi T., Dietel M. Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. Hum Pathol 1997;28(12):1373–8. PMID: 9416693.; Chu P., Arber D.A. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms: frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000;113(3):374–82. DOI:10.1309/8VAV-J2FU-8CU9-EK18. PMID: 10705818.; Chu P.G., Arber D.A., Weiss L.M. Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. an immunohistochemical study of 447 cases. Am J Clin Pathol 2003;120(1):64–70. DOI:10.1309/48KC17WA-U69B-TBXQ. PMID: 12866374.; Aung P.P., Killian K., Poropatich C.O. et al. Primary neuroendocrine tumors of the kidney: morphological and molecular alteration of an uncommon malignancy. Hum Pathol 2013;44(5):873–80. DOI:10.1016/j.humpath.2012.08.013. PMID: 23199527.; Hannah J., Lippe B., Lai-Goldman M., Bhuta S. Oncocytic carcinoid of the kidney associated with periodic Cushing’s syndrome. Cancer 1988;61(10):2136–40. PMID: 3282643.; Hamillton I., Reis L., Bilimoria S. et al. A renal vipoma. Br Med J 1980;281(6251):1323–4. PMID: 7437784.; Gleeson M.H., Bloom S.R., Polak J.M. et al. Endocrine tumour in the kidney affecting small bowel stricter, motility and absorptive function. Gut 1971;12(10): 773–82. PMID: 4941684.; Kawajiri H., Onoda N., Ohira M. et al. Carcinoid tumor of the kidney presenting as a large abdominal mass: report of a case. Surg Today 2004;34(1):86–9. DOI:10.1007/s00595-003-2644-x. PMID: 14714238.; Blomjous C.E., Vos W., Schipper N.W. et al. Morphometric and flow cytometric analysis of small cell undifferentiated carcinoma of the bladder. J Clin Path 1989;42(10):1032–9. PMID: 2555396.; Cramer S.F., Aikawa M., Cebelin M. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer 1981;47(4):724–30. PMID: 6261916.; Eble J.N., Grignon D.J., Young R.H. Tumors of the urinary bladder and urethra. In: Diagnostic histopathology of tumors. Ed.: C.D.M. Fletcher. 4th edn. Philadelphia: Elsevier Saunders, 2013. Pp. 610–637.; Urologic pathology. Eds.: R.O. Peterson, I.A. Sesterhenn, C.J. Davis. 3rd edn. Philadelphia: Lippincott Williams & Wilkins. Pp. 245–249.; Chen Y., Epstein J.I. Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases. Am J Surg Pathol 2011;35(3):442–6. DOI:10.1097/PAS.0b013e318208f96a. PMID: 21317716.; Fernandez-Acenero M.J., Cordova S., Manzarbeitia F., Medina C. Immunohistochemical profile of urothelial and small cell carcinomas of the bladder. Pathol Oncol Res 2011;17(3):519–2. DOI:10.1007/s12253-010-9341-z. PMID: 21203907.; Thompson S., Cioffi-Lavina M., ChapmanFredricks J. et al. Distinction of highgrade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach. Appl Immunohistochem Mol Morphol 2011;19(5):395–9. DOI:10.1097/PAI.0b013e31820eca9a. PMID: 21617524.; Bahrami A., Truong L.D., Ro J.Y. Undifferentiated tumor. True identity by immunohistochemistry. Arch Pathol Lab Med 2008;132(3):326–48. DOI:10.1043/1543-2165(2008)132[326:UTTIBI]2.0.CO;2. PMID: 18318577.; Eble J.N., Young R.H. Carcinoma of the urinary bladder: a review of its diverse morphology. Semin Diagn Pathol 1997;14(2):98–108. PMID: 9179971.; Zhao X., Flynn E.A. Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy. Arch Pathol Lab Med 2012;136(11):1451–9. DOI:10.5858/arpa.2011-0267-RS. PMID: 23106592.; Cheng L., Pan C.X., Yang X.J. et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 2004;101(5):957–62. DOI:10.1002/cncr.20456. PMID: 15329903.; Church D.N., Bahl A. Clinical review – small cell carcinoma of the bladder. Cancer Treat Rev 2006;32(8):588–93. DOI:10.1016/j.ctrv.2006.07.013. PMID: 17008012.; Naturale R.T., Maclennan G.T. Small cell carcinoma of the bladder. J Urol 2006;176(2):781. DOI:10.1016/j.juro.2006.05.021. PMID: 16813945.; Lau S.K., Zhang Y. Pathologic quiz case. A 73-year-old man with a bladder mass. Combined primary small cell neuroendocrine carcinoma and high-grade papillary urothelial carcinoma of the urinary bladder. Arch Pathol Lab Med 2004;128(9):1055–6. DOI:10.1043/1543-2165(2004)1282.0.CO;2. PMID: 15335246.; Sehgal S.S., Wein A.J., Bing Z. et al. Neuroendocrine tumor of the bladder. Rev Urol 2010;12(4):e197–201. PMID: 21234264.; Thota S., Kistangari G., Daw H., Spiro T. A clinical review of small-cell carcinoma of the urinary bladder. Clin Genitourin Cancer 2013;11(2):73–7. DOI:10.1016/j.clgc.2012.11.002. PMID: 23266053.; Ismaili N., Heudel P.E., Elkarak F. et al. Outcome of recurrent and metastatic small cell carcinoma of the bladder. BMC Urol 2009;9:4. DOI:10.1186/1471-2490-9-4. PMID: 19500382.; Choong N.W., Quevedo J.F., Kaur J.S. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 2005;103(6):1172–8. DOI:10.1002/cncr.20903. PMID: 15700264.; Quek M.L., Nichols P.W., Yamzon J. et al. Radical cystectomy for primary neuroendocrine tumors of the bladder: the University of Southern California experience. J Urol 2005;174(1):93–6. DOI:10.1097/01.ju.0000162085.20043.1f. PMID: 15947585.; Siefker-Radtke A.O., Dinney C.P., Abrahams N.A. et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M.D. Anderson cancer experience. J Urol 2004;172(2):481–4. PMID: 15247709.; Lohrisch C., Murray N., Pickles T., Sullivan L. Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer 1999;86(11):2346–52. PMID: 10590377.; Bex A., Nieuwenhuijzen J.A., Kerst M. et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology 2005;65(2):295–9. DOI:10.1016/j.urology.2004.09.049. PMID: 15708041.; Mackey J.R., Au H.J., Hugh J., Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol 1998;159(5):1624–9. DOI:10.1097/00005392-19980500000058. PMID: 9554367.; Chekrine T., De Bari B., Cassier P. et al. Carcinome neuroendocrine à petites cellules de la vessie: à propos d’une observation et revue de littérature. Cancer Radiother 2011;15(3):250–3. DOI:10.1016/j.canrad.2010.11.013. PMID: 21420344.; Elktaibi A., Nasri A., Oukabli M. et al. Carcinome neuroendocrine à petites cellules de la vessie: une entité anatomoclinique rare et agressive. J Afr Cancer Afr J Cancer 2013;5(4):237–9. DOI:10.1007/s12558-013-0283-8.; Macedo L.T., Ribeiro J., Curigliano G. et al. Multidisciplinary approach in the treatment of patients with small cellbladder carcinoma. Eur J Surg Oncol 2011;37(7):558–62. DOI:10.1016/j.ejso.2011.04.005. PMID: 21555200.; Abenoza P., Manivel C., Sibley R.K. Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study. Arch Pathol Lab Med 1986;110(11):1062–6. PMID: 3778122.; Hailemariam S., Gaspert A., Komminoth P. et al. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder. Mod Pathol 1998;11(10):1016–20. PMID: 9796733.; Evans A.J., Al-Maghrabi J., Tsihlias J. et al. Primary large cell neuroendocrine carcinoma of the urinary bladder. Arch Pathol Lab Med 2002;126(10):1229–32. DOI:10.1043/0003-9985(2002)1262.0.CO;2. PMID: 12296766.; Dundr P., Pesl M., Povysil C. et al. Large cell neuroendocrine carcinoma of the urinary bladder with lymphoepithelioma-like features. Pathol Res Pract 2003;199(8):559–63. DOI:10.1078/0344-0338-00462. PMID: 14533941.; Li Y., Outman J.E., Mathur S.C. Carcinosarcoma with a large cell neuroendocrine epithelial component: first report of an unusual biphasic tumour of the urinary bladder. J Clin Pathol 2004;57(3):318–20. PMID: 14990609.; Lee K.H., Ryu S.B., Lee M.C. et al. Primary large cell neuroendocrine carcinoma of the urinary bladder. Pathol Int 2006;56(11):688–93. DOI:10.1111/j.1440-1827.2006.02031.x. PMID: 17040293.; Alijo Serrano F., Sanchez-Mora N., Angel Arranz J. et al. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. Am J Clin Pathol 2007;128(5):733–9. DOI:10.1309/HTREM6QYQDYGNWYA. PMID: 17951193.; Akamatsu S., Kanamaru S., Ishihara M. et al. Primary large cell neuroendocrine carcinoma of the urinary bladder. Int J Urol 2008;15(12):1080–3. DOI:10.1111/j.1442-2042.2008.02168.x. PMID: 19120517.; Bertaccini A., Marchiori D., Cricca A. et al. Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature. Anticancer Res 2008;28(2B):1369–72. PMID: 18505081.; Lee W.J., Kim C.H., Chang S.E. et al. Cutaneous metastasis from large-cell neuroendocrine carcinoma of the urinary bladder expressing CK20 and TTF-1. Am J Dermatopathol 2009;31(2):166–9. DOI:10.1097/DAD.0b013e31818eba4c. PMID: 19318803.; Oshiro H., Gomi K., Nagahama K. et al. Urinary cytologic features of primary large cell neuroendocrine carcinoma of the urinary bladder: a case report. Acta Cytol 2010;54(3):303–10. DOI:10.1159/000325039. PMID: 20518415.; Tsugu A., Yoshiyama M., Matsumae M. Brain metastasis from large cell neuroendocrine carcinoma of the urinary bladder. Surg Neurol Int 2011;109:215–8. DOI:10.1007/978-3-211-99651-5_33. PMID: 20960345.; https://oncourology.abvpress.ru/oncur/article/view/892
-
2Academic Journal
Authors: K. V. Safronova, A. S. Artemieva, A. O. Nuganen, G. F. Kutusheva, D. A. Chuglova, N. A. Mikaya, I. V. Berlev, A. F. Urmancheeva, A. M. Belyaev, E. A. Ulrich, К. В. Сафронова, А. С. Артемьева, А. О. Нюганен, Г. Ф. Кутушева, Д. А. Чуглова, Н. А. Микая, И. В. Берлев, А. Ф. Урманчеева, А. М. Беляев, Е. А. Ульрих
Source: Siberian journal of oncology; Том 19, № 5 (2020); 97-107 ; Сибирский онкологический журнал; Том 19, № 5 (2020); 97-107 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2020-19-5
Subject Terms: шейка матки, neuroendocrine neoplasias, neuroendocrine tumors, cervix, нейроэндокринные неоплазии, нейроэндокринные опухоли
File Description: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/1584/794; Tavassoli F.A., Devilee P. Pathology and genetics of tumors of the breast and female genital organs. WHO, IARC Press. Verh Dtsch Ges Pathol 2002; 86: 116–9.; Kurman R.J., Carcangiu M.L., Herrington C.S. WHO classification of tumours of the female reproductive organs. Lyon IARC Press, 2014. 540 p.; Ambros R.A., Park J.S., Shah K.V., Kurman R.J. Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18. Mod Pathol. 1991 Sep; 4(5): 586–93.; Gadducci A., Carinelli S., Aletti G. Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic on- cologists. Gynecol Oncol. 2017 Mar; 144(3): 637–646. doi:10.1016/j.ygyno.2016.12.003.; Kim J.Y., Hong S.M., Ro J.Y. Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol. 2017 Aug; 29: 11–16. doi:10.1016/j.anndiagpath.2017.04.005.; Guadagno E., De Rosa G., Del Basso De Caro M. Neuroendocrine tumours in rare sites: differences in nomenclature and diagnostics - a rare and ubiquitous histotype. J Clin Pathol. 2016 Jul; 69(7): 563–74. doi:10.1136/jclinpath-2015-203551.; Salvo G., Gonzalez Martin A., Gonzales N.R., Frumovitz M. Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int J Gynecol Cancer. 2019 Jul; 29(6): 986–995. doi:10.1136/ijgc-2019-000504.; Klimstra D.S., Modlin I.R., Coppola D., Lloyd R.V., Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010; 39(6): 707–12. doi:10.1097/MPA.0b013e3181ec124e.; Guadagno E., De Rosa G., Del Basso De Caro M. Neuroendocrine tumours in rare sites: differences in nomenclature and diagnostics-a rare and ubiquitous histotype. J Clin Pathol. 2016; 69(7): 563–74. doi:10.1136/jclinpath-2015-203551.; Travis W.D., Brambilla E., Burke A.P., Marx A., Nicholson A.G. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol. 2015 Sep; 10(9): 1240–1242. doi:10.1097/JTO.0000000000000663.; Chen J., Macdonald O.K., Gaffney D.K. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstet Gynecol. 2008 Jun; 111(6): 1394–402. doi:10.1097/AOG.0b013e318173570b.; Margolis B., Tergas A.I., Chen L., Hou J.Y., Burke W.M., Hu J.C., Ananth C.V., Neugut A.I., Hershman D.L., Wright J.D. Natural history and outcome of neuroendocrine carcinoma of the cervix. Gynecol Oncol. 2016 May; 141(2): 247–254. doi:10.1016/j.ygyno.2016.02.008.; Abeler V.M., Holm R., Nesland J.M., Kjørstad K.E. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer. 1994; 73(3): 672–7. doi:10.1002/1097-0142(19940201)73:33.0.co;2-r.; Toki T., Katayama Y., Motoyama T. Small-cell neuroendocrine carcinoma of the uterine cervix associated with micro-invasive squamous cell carcinoma and adenocarcinoma in situ. Pathol Int. 1996 Jul; 46(7): 520–5. doi:10.1111/j.1440-1827.1996.tb03648.x.; Hara H., Ishii E., Hondo T., Nakagawa M., Teramoto K., Oyama T. Cytological features of atypical carcinoid combined with adenocarcinoma of the uterine cervix. Diagn Cytopathol. 2012 Aug; 40(8): 724–8. doi:10.1002/dc.21657. PMID: 21394936.; Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J.; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 Feb 6; 348(6): 518–27. doi:10.1056/NEJMoa021641.; de Sanjose S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B., Tous S., Felix A., Bravo L.E., Shin H.R., Vallejos C.S., de Ruiz P.A., Lima M.A., Guimera N., Clavero O., Alejo M., LlombartBosch A., Cheng-Yang C., Tatti S.A., Kasamatsu E., Iljazovic E., Odida M., Prado R., Seoud M., Grce M., Usubutun A., Jain A., Suarez G.A., Lombardi L.E., Banjo A., Menéndez C., Domingo E.J., Velasco J., Nessa A., Chichareon S.C., Qiao Y.L., Lerma E., Garland S.M., Sasagawa T., Ferrera A., Hammouda D., Mariani L., Pelayo A., Steiner I., Oliva E., Meijer C.J., Al-Jassar W.F., Cruz E., Wright T.C., Puras A., Llave C.L., Tzardi M., Agorastos T., Garcia-Barriola V., Clavel C., Ordi J., Andújar M., Castellsagué X., Sánchez G.I., Nowakowski A.M., Bornstein J., Muñoz N., Bosch F.X.; Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010; 11(11): 1048–56. doi:10.1016/S1470-2045(10)70230-8.; Alejo M., Alemany L., Clavero O., Quiros B., Vighi S., Seoud M., Cheng-Yang C., Garland S.M., Juanpere N., Lloreta J., Tous S., Klaustermeier J.E., Quint W., Bosch F.X., de Sanjosé S., Lloveras B.; RIS HPV TT study group. Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases. Papillomavirus Res. 2018; 5: 134–142. doi:10.1016/j.pvr.2018.03.005.; Lai C.H., Chang C.J., Huang H.J., Hsueh S., Chao A., Yang J.E., Lin C.T., Huang S.L., Hong J.H., Chou H.H., Wu T.I., Huang K.G., Wang C.C., Chang T.C. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery. J Clin Oncol. 2007 Aug 20; 25(24): 3628–34. doi:10.1200/JCO.2007.11.2995.; Kasuga Y., Miyakoshi K., Nishio H., Akiba Y., Otani T., Fukutake M., Ikenoue S., Ochiai D., Matsumoto T., Tanaka K., Minegishi K., Kuji N., Roberts R., Aoki D., Tanaka M. Mid-trimester residual cervical length and the risk of preterm birth in pregnancies after abdominal radical trachelectomy: a retrospective analysis. BJOG. 2017; 124(11): 1729–1735. doi:10.1111/1471-0528.14688.; Castle P.E., Pierz A., Stoler M.H. A systematic review and metaanalysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecol Oncol. 2018; 148(2): 422–9. doi:10.1016/j.ygyno.2017.12.001.; Howitt B.E., Kelly P., McCluggage W.G. Pathology of Neuroendocrine Tumours of the Female Genital Tract. Curr Oncol Rep. 2017 Sep; 19(9): 59. doi:10.1007/s11912-017-0617-2.; Giorgadze T., Kanhere R., Pang C., Ganote C., Miller L.E., Tabaczka P., Brown E., Husain M. Small cell carcinoma of the cervix in liquid-based Pap test: utilization of split-sample immunocytochemical and molecular analysis. Diagn Cytopathol. 2012 Mar; 40(3): 214–9. doi:10.1002/dc.21542.; McCluggage W.G., Kennedy K., Busam K.J. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am J Surg Pathol. 2010 Apr; 34(4): 525–32. doi:10.1097/PAS.0b013e3181d1d457.; Houghton O., McCluggage W.G. The expression and diagnostic utility of p63 in the female genital tract. Adv Anat Pathol. 2009 Sep; 16(5): 316–21. doi:10.1097/PAP.0b013e3181b507c6.; Chan J.K., Tsui W.M., Tung S.Y., Ching R.C. Endocrine cell hyperplasia of the uterine cervix. A precursor of neuroendocrine carcinoma of the cervix? Am J Clin Pathol. 1989 Dec; 92(6): 825–30. doi:10.1093/ajcp/92.6.825.; Deng G.H., Zhang X., Wu L.Y. Clinicopathological analysis of nine cases of small cell carcinoma of the uterine cervix. Zhonghua Zhong Liu Za Zhi. 2010 Mar; 32(3): 199–202.; Albores-Saavedra J., Gersell D., Gilks C.B., Henson D.E., Lindberg G., Santiago H., Scully R.E., Silva E., Sobin L.H., Tavassoli F.J., Travis W.D., Woodruff J.M. Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med. 1997 Jan; 121(1): 34–9.; Lojek M.A., Fer M.F., Kasselberg A.G., Glick A.D., Burnett L.S., Julian C.G., Greco F.A., Oldham R.K. Cushing’s syndrome with small cell carcinoma of the uterine cervix. Am J Med. 1980; 69(1): 140–4. doi:10.1016/0002-9343(80)90513-6.; Ishibashi-Ueda H., Imakita M., Yutani C., Ohmichi M., Chiba Y., Kubo T., Waki M. Small cell carcinoma of the uterine cervix with syndrome of inappropriate antidiuretic hormone secretion. Mod Pathol. 1996 Apr; 9(4): 397–400.; Koch C.A., Azumi N., Furlong M.A., Jha R.C., Kehoe T.E., Trowbridge C.H., O’Dorisio T.M., Chrousos G.P., Clement S.C. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab. 1999 Nov; 84(11): 4209–13. doi:10.1210/jcem.84.11.6126.; Boruta D.M.2nd, Schorge J.O., Duska L.A., Crum C.P., Castrillon D.H., Sheets E.E. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol. 2001; 81(1): 82–7. doi:10.1006/gyno.2000.6118.; Wang H.L., Lu D.W. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol. 2004; 28(7): 901–8. doi:10.1097/00000478-200407000-00009.; Kuroda N., Wada Y., Inoue K., Ohara M., Mizuno K., Toi M., Tanaka A., Wani Y., Yanai H. Smear cytology findings of large cell neuroendocrine carcinoma of the uterine cervix. Diagn Cytopathol. 2013; 41(7): 636–9. doi:10.1002/dc.21834.; Dongol S., Tai Y., Shao Y., Jiang J., Kong B. A retrospective clinicopathological analysis of small-cell carcinoma of the uterine cervix. Mol Clin Oncol. 2014 Jan; 2(1): 71–75. doi:10.3892/mco.2013.193.; Hoskins P.J., Wong F., Swenerton K.D., Pike J.A., Manji M., McMurtrie E., Acker B., Le Riche J. Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide. Gynecol Oncol. 1995; 56(2): 218–25. doi:10.1006/gyno.1995.1035.; Hoskins P.J., Swenerton K.D., Pike J.A., Lim P., Aquino-Parsons C., Wong F., Lee N. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol. 2003 Sep 15; 21(18): 3495–501. doi:10.1200/JCO.2003.01.501.; Chang T.C., Lai C.H., Tseng C.J., Hsueh S., Huang K.G., Chou H.H. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer. 1998 Aug 15; 83(4): 712–8. doi:10.1002/(sici)1097-0142(19980815)83:43.0.co;2-v.; Viswanathan A.N., Deavers M.T., Jhingran A., Ramirez P.T., Levenback C., Eifel P.J. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004 Apr; 93(1): 27–33. doi:10.1016/j.ygyno.2003.12.027.; Zivanovic O., Leitao M.M.Jr., Park K.J., Zhao H., Diaz J.P., Konner J., Alektiar K., Chi D.S., Abu-Rustum N.R., Aghajanian C. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecol Oncol. 2009 Mar; 112(3): 590–3. doi:10.1016/j.ygyno.2008.11.010.; Chan J.K., Loizzi V., Burger R.A., Rutgers J., Monk B.J. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer. 2003; 97: 568–574.; Wang K.L., Chang T.C., Jung S.M., Chen C.H., Cheng Y.M., Wu H.H., Liou W.S., Hsu S.T., Ou Y.C., Yeh L.S., Lai H.C., Huang C.Y., Chen T.C., Chang C.J., Lai C.H. Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: a Taiwanese Gynecologic Oncology Group study. Eur J Cancer. 2012; 48(10): 1484–94. doi:10.1016/j.ejca.2011.12.014.; Bermúdez A., Vighi S., García A., Sardi J. Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge. Gynecol. Oncol. 2001; 82: 32–39.; Sheets E.E., Berman M.L., Hrountas C.K., Liao S.Y., DiSaia P.J. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol. 1988 Jan; 71(1): 10–14.; Nasu K., Hirakawa T., Okamoto M., Nishida M., Kiyoshima C., Matsumoto H., Takai N., Narahara H. Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery. Rare Tumors. 2011 Mar 30; 3(1): e6. doi:10.4081/rt.2011.e6.; Krivak T.C, McBroom J.W., Sundborg M.J., Crothers B., Parker M.F. Large cell neuroendocrine cervical carcinoma: a report of two cases and review of the literature. Gynecol Oncol. 2001; 82(1): 187–91. doi:10.1006/gyno.2001.6254.; Gilks C.B., Young R.H., Gersell D.J., Clement P.B. Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol. 1997 Aug; 21(8): 905–14. doi:10.1097/00000478-199708000-00004.; Sato Y., Shimamoto T., Amada S., Asada Y., Hayashi T. Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathological study of six cases. Int J Gynecol Pathol. 2003 Jul; 22(3): 226–30. doi:10.1097/01.PGP.0000071046.12278.D1.; Embry J.R., Kelly M.G., Post M.D., Spillman M.A. Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy. Gynecol Oncol. 2011 Mar; 120(3): 444–8. doi:10.1016/j.ygyno.2010.11.007.; Rhemtula H., Grayson W., van Iddekinge B., Tiltman A. Large-cell neuroendocrine carcinoma of the uterine cervix--a clinicopathological study of five cases. S Afr Med J. 2001 Jun; 91(6): 525–8.; Emerson R.E., Michael H., Wang M., Zhang S., Roth L.M., Cheng L. Cervical Carcinomas With Neuroendocrine Differentiation: A Report of 28 Cases With Immunohistochemical Analysis and Molecular Genetic Evidence of Common Clonal Origin With Coexisting Squamous and Adenocarcinomas. Int J Gynecol Pathol. 2016 Jul; 35(4): 372–84. doi:10.1097/PGP.0000000000000254.; Futagami M., Yokoyama Y., Mizunuma H. Presentation of a patient with pT2bN1M0 small cell carcinoma of the uterine cervix who obtained long-term survival with maintenance chemotherapy, and literature-based discussion. Eur J Gynaecol Oncol. 2011; 32(1): 99–102.; Yoseph B., Chi M., Truskinovsky A.M., Dudek A.Z. Large-cell neuroendocrine carcinoma of the cervix. Rare Tumors. 2012 Jan 2; 4(1): e18. doi:10.4081/rt.2012.e18.; https://www.siboncoj.ru/jour/article/view/1584
-
3Academic Journal
Authors: Mikhaleva L.M., Vasyukova O.A., Birukov A.E., Midiber K.Y., Akopyan E.P., Khovanskaya T.N., Guschin M.Y.
Contributors: 0
Source: Annals of the Russian academy of medical sciences; Vol 75, No 2 (2020); 169-177 ; Вестник Российской академии медицинских наук; Vol 75, No 2 (2020); 169-177 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.752
Subject Terms: gastric neuroendocrine neoplasia, neuroendocrine carcinoma, mixed neuroendocrine-non-neuroendocrine neoplasms, immunohistochemistry methods, gastrointestinal endoscopy methods, нейроэндокринные неоплазии желудка, нейроэндокринная карцинома, MiNEN, иммуногистохимические методы, эндоскопическая диагностика в гастроэнтерологии
File Description: application/pdf
Relation: https://vestnikramn.spr-journal.ru/jour/article/view/1258/1195; https://vestnikramn.spr-journal.ru/jour/article/view/1258/1225; https://vestnikramn.spr-journal.ru/jour/article/view/1258/1244; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1258/1189